about
Artemisinin combination therapy for vivax malariaThe anaemia of Plasmodium vivax malariaPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureMajor burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance studySevere malarial thrombocytopenia: a risk factor for mortality in Papua, IndonesiaNew developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivaxAn outbreak of Pontiac fever due to Legionella longbeachae serogroup 2 found in potting mix in a horticultural nursery in New Zealand.Plasmodium vivax treatments: what are we looking for?Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study.Plasmodium vivax infection: a major determinant of severe anaemia in infancy.Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early LifeSubmicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, IndonesiaChemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria.Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.Maximising the public health benefit of antimalarials.Artemisinin combination therapy for malaria: beyond good efficacy.Survival by ethnicity for children diagnosed with cancer in New Zealand during 1990-1993.High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia.Expanding the use of primaquine for the radical cure of Plasmodium vivaxField evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activityRisk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysisPopulation-based survival of children in New Zealand diagnosed with cancer during 1990–1993Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysisMalaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
P50
Q24622539-D63BE8B9-613C-4961-94E8-28C987A45286Q27026970-FD5E7100-7AE5-4EC4-B39D-E1B265D78912Q27027939-7F89E8D4-C33C-4187-8099-630D47D14D50Q28537653-DE019E68-E66D-421B-A102-E92EB46A3A98Q33417393-EC34E4F5-2D2B-45D1-9988-3D1DC6F1D6B0Q33477285-C003FC0E-0F4B-4BC7-8314-3380FDEA1715Q34314662-712A0263-D8A5-413C-A0A7-3BDF3E5F6603Q34699136-FFC2A6C5-84C7-4156-88FA-05A174E1A0E9Q34772862-888EE5C0-F895-449C-AE2C-67483E28951BQ35005218-6F180ECF-BF9B-448F-B643-643FFBAAAA2AQ35760893-1F68EB64-0779-4EC8-8FA0-1E81AA0608A4Q35882487-B9A25328-46E7-45D8-9350-B5C55C5FCF88Q36053392-FBE56935-3E9A-49C4-A0E9-FBD8ECFB8E30Q36098613-275F8B5D-BF3D-4C97-84B9-B70BA7499966Q36176399-BCF6A700-D009-453E-9216-54B556A7031DQ38063986-118ADBB6-0422-4981-A672-E302422043E5Q38603812-67ED00E5-EC01-4A63-80C0-2F2D6400446DQ42910618-EC679CF1-6838-40FF-95B8-162FF56ADE90Q43195191-7CD7B32B-BC3E-466D-99A8-678C7E807B22Q47575340-2A9CCB78-F4EA-462B-BBB8-EBC0B5E491DBQ54208945-CDF4C5BE-C580-43EA-8527-C55FBC579082Q56366262-1AAF01A3-7632-4C0C-B01C-B1146253B09BQ58617977-29FC0EC7-CFDC-4C7C-A9F0-6799E0BDC3F3Q60923156-287E4B2A-8964-4AAC-B564-FD8CD00B6F0EQ61714751-DBA3F30B-CE09-46DE-9100-C58A86F27C86Q64962925-EAD546D5-3401-448C-A898-790468AC87E2Q91959120-8B8AC1F4-E7F8-4292-8BD6-8A88CC82325DQ93031691-0EC98BF0-BF40-4AB8-A322-606130726A0D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicholas M. Douglas
@ast
Nicholas M. Douglas
@en
Nicholas M. Douglas
@es
Nicholas M. Douglas
@nl
Nicholas M. Douglas
@sl
type
label
Nicholas M. Douglas
@ast
Nicholas M. Douglas
@en
Nicholas M. Douglas
@es
Nicholas M. Douglas
@nl
Nicholas M. Douglas
@sl
prefLabel
Nicholas M. Douglas
@ast
Nicholas M. Douglas
@en
Nicholas M. Douglas
@es
Nicholas M. Douglas
@nl
Nicholas M. Douglas
@sl
P106
P1153
34978487600
P21
P31
P496
0000-0002-7214-4244